Complex Exercise Program for Stroke Patients (CEPS)

August 13, 2023 updated by: Sung-Hwa Ko, Pusan National University Yangsan Hospital

Safety and Cardiopulmonary Efficacy of Complex Exercise Program for Stroke Patients in the Community

The physical and social effects of exercise programs and daily exercise have already been demonstrated in stroke. However, stroke survivors have shown a passive attitude towards the exercise program and there was little guideline and experience of the stroke exercise program in the community. Therefore, the study provides patients with an adequate guide to a complex exercise program after discharge based on the medical records.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Gyeongnam
      • Yangsan, Gyeongnam, Korea, Republic of, 50612
        • Recruiting
        • Pusan National University Yangsan Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Community indwelling stroke patients discharged from Pusan National University Yangsan Hospital
  • Independent ambulator (FAC over 4)
  • Independent daily activities (Modified Rankin Scale less than 2)
  • No apparent spasticity on hemiplegic side (Modified Ashworth scale less than 1)
  • Hemiplegic side motor grades (Manual muscle testing, MMT) more than 3

Exclusion Criteria:

  • MMSE less than 18
  • BBS less than 41
  • Severe aphagia who cannot communicate
  • Severe cardiovascular conditions inhibiting exercise programs
  • Musculoskeletal problems inhibiting exercise programs
  • Other medical conditions considered by physiatrists

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Group with exercise program
Stretching exercise, aerobic exercise, strengthening and balancing exercise
No Intervention: Control group
Group without exercise program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peak VO2
Time Frame: Baseline evaluation
Maximal VO2 from cardiopulmonary exercise test
Baseline evaluation
Peak VO2
Time Frame: Follow-up evaluation (through study completion, an average of 6 weeks)
Maximal VO2 from cardiopulmonary exercise test
Follow-up evaluation (through study completion, an average of 6 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Timed up and go
Time Frame: Baseline evaluation
To determine fall risk and measure the progress of balance
Baseline evaluation
Grip strength
Time Frame: Baseline evaluation
measure of muscular strength or the maximum force/tension generated by one's forearm muscles
Baseline evaluation
6-minute walk test
Time Frame: Baseline evaluation
practical simple test that requires a 100-ft hallway but no exercise equipment or advanced training for technicians
Baseline evaluation
Figure-of-eight walk test
Time Frame: Baseline evaluation
Measurement tool that assesses the ability to walk on a curved path
Baseline evaluation
Sit-and-reach test
Time Frame: Baseline evaluation
Measure of flexibility, and specifically measures the flexibility of the lower back and hamstring muscles
Baseline evaluation
Chair sit-to-stand test
Time Frame: Baseline evaluation
Testing leg strength and endurance in older adults
Baseline evaluation
Body composition analysis
Time Frame: Baseline evaluation
Percentage of fat, bone, and muscle in the body
Baseline evaluation
Functional ambulation category (0-5, the higher the better)
Time Frame: Baseline evaluation
6-point functional walking test that evaluates ambulation ability
Baseline evaluation
Functional ambulation category (0-5, the higher the better)
Time Frame: Follow-up evaluation (through study completion, an average of 6 weeks)
6-point functional walking test that evaluates ambulation ability
Follow-up evaluation (through study completion, an average of 6 weeks)
Berg balance scale (0-56, the higher the better)
Time Frame: Baseline evaluation
Objectively determine a patient's ability to safely balance during a series of predetermined tasks
Baseline evaluation
Berg balance scale (0-56, the higher the better)
Time Frame: Follow-up evaluation (through study completion, an average of 6 weeks)
Objectively determine a patient's ability to safely balance during a series of predetermined tasks
Follow-up evaluation (through study completion, an average of 6 weeks)
Timed up and go
Time Frame: Follow-up evaluation (through study completion, an average of 6 weeks)
To determine fall risk and measure the progress of balance
Follow-up evaluation (through study completion, an average of 6 weeks)
Grip strength
Time Frame: Follow-up evaluation (through study completion, an average of 6 weeks)
measure of muscular strength or the maximum force/tension generated by one's forearm muscles
Follow-up evaluation (through study completion, an average of 6 weeks)
6-minute walk test
Time Frame: Follow-up evaluation (through study completion, an average of 6 weeks)
practical simple test that requires a 100-ft hallway but no exercise equipment or advanced training for technicians
Follow-up evaluation (through study completion, an average of 6 weeks)
Figure-of-eight walk test
Time Frame: Follow-up evaluation (through study completion, an average of 6 weeks)
Measurement tool that assesses the ability to walk on a curved path
Follow-up evaluation (through study completion, an average of 6 weeks)
Sit-and-reach test
Time Frame: Follow-up evaluation (through study completion, an average of 6 weeks)
Measure of flexibility, and specifically measures the flexibility of the lower back and hamstring muscles
Follow-up evaluation (through study completion, an average of 6 weeks)
Chair sit-to-stand test
Time Frame: Follow-up evaluation (through study completion, an average of 6 weeks)
Testing leg strength and endurance in older adults
Follow-up evaluation (through study completion, an average of 6 weeks)
Fugl-Meyer assessment (0-226, the higher the better)
Time Frame: Baseline evaluation
Stroke-specific, performance-based impairment index
Baseline evaluation
Fugl-Meyer assessment (0-226, the higher the better)
Time Frame: Follow-up evaluation (through study completion, an average of 6 weeks)
Stroke-specific, performance-based impairment index
Follow-up evaluation (through study completion, an average of 6 weeks)
Manual function test (0-32, the higher the better)
Time Frame: Baseline evaluation
Evaluate unilateral manual performance in hemiparetic patients after stroke
Baseline evaluation
Manual function test (0-32, the higher the better)
Time Frame: Follow-up evaluation (through study completion, an average of 6 weeks)
Evaluate unilateral manual performance in hemiparetic patients after stroke
Follow-up evaluation (through study completion, an average of 6 weeks)
Modified Barthel Index (Korean version) (0-100, the higher the better)
Time Frame: Baseline evaluation
Measure of physical disability used widely to assess behaviour relating to activities of daily living
Baseline evaluation
Modified Barthel Index (Korean version) (0-100, the higher the better)
Time Frame: Follow-up evaluation (through study completion, an average of 6 weeks)
Measure of physical disability used widely to assess behaviour relating to activities of daily living
Follow-up evaluation (through study completion, an average of 6 weeks)
Body composition analysis
Time Frame: Follow-up evaluation (through study completion, an average of 6 weeks)
Percentage of fat, bone, and muscle in the body
Follow-up evaluation (through study completion, an average of 6 weeks)
Korean Mini-Mental Status Examination (K-MMSE) (0-30, the higher the better)
Time Frame: Baseline evaluation
Screening of dementia and to investigate the possible changes of optimal cutoff scores
Baseline evaluation
Korean Mini-Mental Status Examination (K-MMSE) (0-30, the higher the better)
Time Frame: Follow-up evaluation (through study completion, an average of 6 weeks)
Screening of dementia and to investigate the possible changes of optimal cutoff scores
Follow-up evaluation (through study completion, an average of 6 weeks)
Euro-Quality of Life-5 Dimension (EQ-5D) (5-25, the higher the better)
Time Frame: Baseline evaluation
A brief and simple instrument measuring health related quality of life
Baseline evaluation
Euro-Quality of Life-5 Dimension (EQ-5D) (5-25, the higher the better)
Time Frame: Follow-up evaluation (through study completion, an average of 6 weeks)
A brief and simple instrument measuring health related quality of life
Follow-up evaluation (through study completion, an average of 6 weeks)
Getriatic depression scale (0-15, the higher the more depressive)
Time Frame: Baseline evaluation
Assessment of depression in the elderly
Baseline evaluation
Getriatic depression scale (0-15, the higher the more depressive)
Time Frame: Follow-up evaluation (through study completion, an average of 6 weeks)
Assessment of depression in the elderly
Follow-up evaluation (through study completion, an average of 6 weeks)
International Physical Activity Questionnaire (No scores)
Time Frame: Baseline evaluation
27-item self-reported measure of physical activity for use with individual adult patients aged 15 to 69 years old
Baseline evaluation
International Physical Activity Questionnaire (No scores)
Time Frame: Follow-up evaluation (through study completion, an average of 6 weeks)
27-item self-reported measure of physical activity for use with individual adult patients aged 15 to 69 years old
Follow-up evaluation (through study completion, an average of 6 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 18, 2022

Primary Completion (Estimated)

December 31, 2023

Study Completion (Estimated)

December 31, 2023

Study Registration Dates

First Submitted

October 31, 2022

First Submitted That Met QC Criteria

November 7, 2022

First Posted (Actual)

November 15, 2022

Study Record Updates

Last Update Posted (Actual)

August 15, 2023

Last Update Submitted That Met QC Criteria

August 13, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Complex exercise program

Subscribe